On September 1, 2021 Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, reported Helen Sabzevari, PhD, President and CEO of Precigen, will participate in two upcoming conferences (Press release, Precigen, SEP 1, 2021, https://www.prnewswire.com/news-releases/precigen-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference-and-the-hc-wainwright-23rd-annual-global-investment-conference-301366548.html [SID1234587133]). Dr. Sabzevari will participate in a virtual fireside chat at the 2021 Wells Fargo Virtual Healthcare Conference on Thursday, September 9, 2021 at 8:40 AM ET, and present at the H.C. Wainwright 23rd Annual Global Investment Conference. The H.C. Wainwright webcast will be available on-demand beginning Monday, September 13, 2021 at 7:00 AM ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Participants may access the webcasts for these events through Precigen’s website in the Press & Events section at investors.precigen.com/events-presentations.